Literature DB >> 15870571

The impact of diabetic retinopathy on health-related quality of life.

Sanjay Sharma1, Alejandro Oliver-Fernandez, Wei Liu, Patricia Buchholz, John Walt.   

Abstract

PURPOSE OF REVIEW: To review recent evidence evaluating the effect of diabetic retinopathy and diabetic macular edema on health-related quality of life. RECENT
FINDINGS: A search of PubMed was conducted according to a strategy that combined the text words 'diabetic retinopathy' and 'quality of life' (n = 91; November 11, 2004) and 'diabetic macular edema' and 'quality of life' (n = 6; November 22, 2004). The Methods sections of all abstracts were reviewed for valid generic or disease-specific instruments used to evaluate health-related quality of life. In addition, abstracts were reviewed to ensure that the study sample was made up predominantly of diabetic individuals. Recent data suggest that persons with diabetic retinopathy are willing to trade off significant time to eliminate their ocular condition (mean time tradeoff score = 0.77-0.8) and that laser photocoagulation can improve health-related quality of life (significant improvement noted in 8 of 11 domains in the National Eye Institute Visual Function Questionnaire). In addition, recent research has noted that health-related quality of life can become affected in persons with diabetic retinopathy prior to visual loss, primarily because of anxiety about the future and emotional reaction to diagnosis and treatment.
SUMMARY: From a search of the literature, several recent articles could be identified that demonstrated both a qualitative and a quantitative reduction in health-related quality of life in persons with diabetic retinopathy. With many novel treatments being explored for the management of diabetic retinopathy and diabetic macular edema, measuring health-related quality of life will likely play an important role both in the decision to offer treatment and in monitoring relevant health gains that may be derived from intervention.

Entities:  

Mesh:

Year:  2005        PMID: 15870571     DOI: 10.1097/01.icu.0000161227.21797.3d

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  30 in total

1.  Psychometric performance of the national eye institute 25-item visual function questionnaire: in Turkish diabetic retinopathy patients.

Authors:  Akinci Fevzi; Yildirim Aysegul
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

2.  Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study.

Authors:  Kashif Mazhar; Rohit Varma; Farzana Choudhury; Roberta McKean-Cowdin; Corina J Shtir; Stanley P Azen
Journal:  Ophthalmology       Date:  2010-10-29       Impact factor: 12.079

3.  Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.

Authors:  Jeffrey R Willis; Quan V Doan; Michelle Gleeson; Zdenka Haskova; Pradeep Ramulu; Lawrence Morse; Ronald A Cantrell
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

4.  Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes.

Authors:  Sul Gee Lee; Jung Lim Kim; Han Kee Lee; Gyu Won Ryu; Dae Young Hur; Il Han Yun; Jae Wook Yang; Hyun Woong Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-07       Impact factor: 3.117

5.  Quality of Life in People with Diabetic Retinopathy: Indian Study.

Authors:  Datson Marian Pereira; Amish Shah; May D'Souza; Paul Simon; Thomas George; Nameeth D'Souza; Sucharitha Suresh; Manjeshwar Shrinath Baliga
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 6.  How the diabetic eye loses vision.

Authors:  Jaime A Davidson; Thomas A Ciulla; Janet B McGill; Keri A Kles; Pamela W Anderson
Journal:  Endocrine       Date:  2007-09-27       Impact factor: 3.633

7.  Microperimetry in diabetic retinopathy.

Authors:  Edoardo Midena; Stela Vujosevic
Journal:  Saudi J Ophthalmol       Date:  2011-01-31

Review 8.  Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

Authors:  Sally A Madsen-Bouterse; Renu A Kowluru
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

9.  Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.

Authors:  Joshua D Stein; Paula Anne Newman-Casey; David D Kim; Kristen Harris Nwanyanwu; Mark W Johnson; David W Hutton
Journal:  Ophthalmology       Date:  2013-05-01       Impact factor: 12.079

10.  Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats.

Authors:  Abdulrahman L Al-Malki
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.